10-K Decoder · All companies

Novavax, Inc.

NVAX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$1.12B$682M+64.7%
Operating income$453M−$249M
Net income$440M−$188M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$68.3M$70.4M−3.0%
Operating income−$31.3M−$178M+82.4%
Net income−$31.4M−$202M+84.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Novavax's revenue in FY2025?
$1.12B in FY2025 (Fiscal year ended Dec 31, 2025), +64.7% vs $682M a year earlier, per its 10-K filed Feb 2026.
Was Novavax profitable in FY2025?
Yes: net income was $440M and operating income $453M in FY2025.
What was Novavax's revenue in Q3 2026?
$68.3M (−3.0% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.